期刊文献+

Mesenchymal stem cells for the treatment of tendon disorders

Mesenchymal stem cells for the treatment of tendon disorders
下载PDF
导出
摘要 Tendon disorders are associated with increased morbidity and a reduction in the quality of life, especially in people of working age. Recently, a new approach, cell-based therapy, offers promising potential to treat tendon injuries. Mesenchymal stem cells are the most suitable candidates for such therapies due to their capacity to differentiate into cells of mesodermal origin, their paracrine properties and their potential use in autologous transplantation. This review summarizes experimental as well as clinical data focusing on the use of mesenchymal stem cells to treat tendinophaties. Tendon disorders are associated with increased morbidity and a reduction in the quality of life, especially in people of working age. Recently, a new approach, cell-based therapy, offers promising potential to treat tendon injuries. Mesenchymal stem cells are the most suitable candidates for such therapies due to their capacity to differentiate into cells of mesodermal origin, their paracrine properties and their potential use in autologous transplantation. This review summarizes experimental as well as clinical data focusing on the use of mesenchymal stem cells to treat tendinophaties.
出处 《Journal of Biomedical Science and Engineering》 2013年第8期14-23,共10页 生物医学工程(英文)
关键词 Tendinophaty TENDINOSIS TENDONITIS Models of TENDON Injuries Mesenchymal Stem Cells ROTATOR CUFF ACHILLES TENDON TENDON Rupture Tendinophaty Tendinosis Tendonitis Models of Tendon Injuries Mesenchymal Stem Cells Rotator Cuff Achilles Tendon Tendon Rupture
  • 相关文献

参考文献2

二级参考文献10

  • 1UK Prospective Diabetes Study Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[].The Lancet.1998
  • 2Shapiro AM,,Lakey JR,Ryan EA,Korbutt GS,Toth E,Warnock GL, et al.Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen[].The New England Journal of Medicine.2000
  • 3Gunnarsson R,Klintmalm G,Lundgren G,Wilczek H,Ostman J,Groth CG.Deterioration in glucose metabolism in pancreatic transplant recipients given cyclosporine[].The Lancet.1983
  • 4Assady S,Maor G,Amit M,Itskovitz-Eldor J,Skorecki KL,Tzukerman M.Insulin production by human embryonic stem cells[].Diabetes.2001
  • 5Yang L,Li S,Hatch H,Ahrens K,Cornelius JG,Petersen BE.Peck AB: In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine homone-producing cells[].Proceedings of the National Academy of Sciences of the United States of America.2002
  • 6Bonner-Weir S,Taneja M,Weir GC,Tatarkiewicz K,Song KH,Sharma A,et al.In vitro cultivation of human islets from expanded ductal tissue[].Proceedings of the National Academy of Sciences of the United States of America.2000
  • 7Ramiya VK,Maraist M,Arfors KE,Schatz DA,Peck AB,Cornelius JG.Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells[].Nature Medicine.2000
  • 8Timper K,Seboek D,Eberhardt M,Linscheid P,Christ-Crain M,Keller U,Müller B,Zulewski H.Human adipose tissue-derived mesenchymal stem cells differenti- ate into insulin,somatostatin,and glucagon expressing cells[].Biochemical and Biophysical Research Communica- tions.2006
  • 9Pittenger MF,Mackay AM,Beck SC,Jaiswal RK,Douglas R,Mosca JD et al.Multilineage potential of adult human mesenchymal stem cells[].Science.1999
  • 10Krause,DS,Theise,ND,Collector,MI,Henegariu,O,Hwang,S,Gardner,R,Neutzel,S,Sharkis,SJ.Multi-organ, mutli-lineage engraftment by a single bone marrow[].derived stem cell Cell.2001

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部